货号：UP885240564
| 产品信息 | |
| 产品名称： | CI-994 |
| 中文名称： | 4-乙酰氨基-N-(2'-氨基苯基)-苯甲酰胺(请以英文为准,中文仅做参考) |
| CAS号： | 112522-64-2 |
| 分子式： | C15H15N3O2 |
| 分子量： | 269.30 |
| MDL NO： | MFCD00866266 |
| 标准纯度： | 98+% (UP885240564) |
| 沸点： | - |
| 储存： | Keep in dark place,Inert atmosphere,2-8°C (UP885240564) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
抑制剂/受体激动剂
表观遗传学
HIF
抑制剂/受体激动剂
表观遗传学
Epigenetic Reader Domain
抑制剂/受体激动剂
表观遗传学
Histone Acetyltransferase
alpha-Asarone
UP2693810342883-98-9
Potassium 2-hydroxy-4-methoxybenzoate
UP492128458152312-71-5
Methyl trans-p-Coumarate
UP99313746919367-38-5
Sodium 2-chloro-2,2-difluoroacetate
UP5056125681895-39-2
Remodelin
UP254845953949912-58-7
Geldanamycin
UP75949665330562-34-6
Corynoxine B
UP96506089217391-18-3
Sodium 2-(1H-indol-3-yl)acetate
UP2646587056505-45-9
Fangchinoline
UP722456938436-77-1
Cilostazol
UP54014932773963-72-1
Gelsemine
UP149752999509-15-9
Gossypol
UP719039192303-45-7
Esculin
UP458590044531-75-9
AZ505
UP4549344021035227-43-0
SR-9011
UP7604225051379686-29-9
GSK256066
UP185039382801312-28-7
Potassium succinate trihydrate
UP455984492676-47-1
Olprinone Hydrochloride
UP254465673119615-63-3
Nimodipine
UP27631141366085-59-4
Dipyridamole
UP32680818758-32-2
Chrysoeriol
UP167579487491-71-4
Synephrine hydrochloride
UP8721224065985-28-4
Chidamide
UP373372054743420-02-2
3,4-Dicaffeoylquinic Acid
UP57230510314534-61-3
Sodium 2-phenoxyacetate hydrate
UP486266525313222-85-4
Adrafinil
UP39930025663547-13-7
Ammonium 2-sulfobenzoate
UP5980842996939-89-5
Oroxylin A
UP940826130480-11-5
1-Cyclopentyl-1-tosylmethyl isocyanide
UP6000488241048971-66-9
Potassium pivalate
UP72964189219455-23-3
PP242
UP9484379991092351-67-1
Olivetol
UP306276293500-66-3
Liquiritin
UP187829909551-15-5
Mivebresib
UP9374049801445993-26-9
M344
UP799396535251456-60-7
Moracin M
UP37323179256317-21-6
Sodium 5-bromo-2-hydroxybenzoate
UP43834932237717-99-0
Sodium 5-amino-2-hydroxybenzoate
UP58994110935589-28-7
CG200745
UP314090846936221-33-9
MIM1
UP525843989509102-00-5
GSK525768A
UP6919166181260530-25-3
Amiodarone Hydrochloride
UP74813058419774-82-4
Potassium heptadecanoate
UP73008568617378-36-8
Palmitic Acid Methyl Ester
UP530600452112-39-0
TAK-915
UP8779022191476727-50-0
Pimobendan hydrochloride
UP58115442277469-98-8
Ethyl Ferulate
UP2911330534046-02-0
sn-Glycero-3-phosphocholine
UP99029594528319-77-9
Pyroxamide
UP751012016382180-17-8
LMK-235
UP5481458411418033-25-6
AT-101
UP28756819690141-22-3
Nocodazole
UP84529801131430-18-9
4-Hydroxybenzyl alcohol
UP543717810623-05-2
UNC669
UP3035526881314241-44-5
(3aR,4R,6aS)-4-(((tert-Butyldimethylsilyl)oxy)methyl)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyrrole
UP913755470153172-31-7
(2,4-Dimethylphenyl)(2-nitrophenyl)sulfane
UP4826123891610527-49-5
PI-103
UP216228573371935-74-9
Potassium acetate
UP633139838127-08-2
Irbesartan
UP581598767138402-11-6
2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
UP5555092271261295-10-6
Vidofludimus
UP796127965717824-30-1
Efaproxiral sodium
UP673493458170787-99-2
Calcium folinate
UP9946130901492-18-8
Bestatin
UP34728073858970-76-6
6-Maleimidohexanoic acid
UP19593033755750-53-3
Hydrocinnamic Acid
UP568471682501-52-0
trans-Cinnamaldehyde
UP32196249114371-10-9
Candesartan cilexetil
UP297926358145040-37-5
4-Chloro-5H-pyrrolo[3,2-d]pyrimidine
UP89491650484905-80-6
Bestatin trifluoroacetate
UP454730943223763-80-2
CBB1007
UP3483508101379573-92-8
Sodium pentanoate
UP6518227046106-41-8
UF010
UP387323820537672-41-6
Hydroxychloroquine sulfate
UP260070271747-36-4
HA130
UP3404964251229652-21-4
Ammonium oxalate
UP3835345111113-38-8
AN-3199
UP4838453951187187-10-5
4'-Hydroxyacetophenone
UP67307527999-93-4
CI-994
UP885240564112522-64-2